9.4 Lipid nanostructures

Lipid nanostructures are tiny systems made of fats that can carry and deliver various biological compounds. They offer benefits like being compatible with the body, breaking down safely, and helping poorly water-soluble drugs dissolve better.

There are several types of lipid nanostructures, each with unique features. These include liposomes, solid lipid nanoparticles, nanostructured lipid carriers, lipid nanocapsules, lipid nanoemulsions, and lipid-based micelles. Each type has specific uses in nanobiotechnology and drug delivery.

Types of lipid nanostructures

• Lipid nanostructures are nanoscale systems composed of lipids that can encapsulate and deliver various bioactive compounds
• They offer advantages such as biocompatibility, biodegradability, and the ability to solubilize poorly water-soluble drugs
• Different types of lipid nanostructures exist, each with unique characteristics and applications in nanobiotechnology

Liposomes

Top images from around the web for Liposomes

• 

  Frontiers | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases View original

  Is this image relevant?

• 

  Frontiers | A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable ... View original

  Is this image relevant?

• 

  Frontiers | Advances and Challenges of Liposome Assisted Drug Delivery View original

  Is this image relevant?

• 

  Frontiers | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases View original

  Is this image relevant?

• 

  Frontiers | A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable ... View original

  Is this image relevant?

1 of 3

Top images from around the web for Liposomes

• 

  Frontiers | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases View original

  Is this image relevant?

• 

  Frontiers | A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable ... View original

  Is this image relevant?

• 

  Frontiers | Advances and Challenges of Liposome Assisted Drug Delivery View original

  Is this image relevant?

• 

  Frontiers | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases View original

  Is this image relevant?

• 

  Frontiers | A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable ... View original

  Is this image relevant?

1 of 3

• Spherical vesicles composed of one or more phospholipid bilayers surrounding an aqueous core
• Can encapsulate both hydrophilic and hydrophobic compounds
• Widely used in drug delivery, gene therapy, and vaccine development
• Examples include Doxil (liposomal doxorubicin) and AmBisome (liposomal amphotericin B)

Solid lipid nanoparticles (SLNs)

• Nanoparticles composed of solid lipids at room and body temperature
• Provide controlled drug release and improved stability compared to liposomes
• Can incorporate lipophilic drugs and protect them from degradation
• Examples include SLN-based topical formulations for skin delivery and oral SLNs for enhanced bioavailability

Nanostructured lipid carriers (NLCs)

• Second-generation lipid nanoparticles that combine solid and liquid lipids
• Offer higher drug loading capacity and reduced drug expulsion compared to SLNs
• Can be tailored for specific drug release profiles and targeting
• Examples include NLC-based formulations for ocular drug delivery and anti-cancer therapy

Lipid nanocapsules

• Nanovesicles with an oily core surrounded by a solid lipid shell
• Provide high encapsulation efficiency for lipophilic compounds
• Can enhance oral bioavailability and drug transport across biological barriers
• Examples include lipid nanocapsules for the delivery of essential oils and antioxidants

Lipid nanoemulsions

• Nanoscale emulsions composed of oil droplets dispersed in an aqueous phase, stabilized by surfactants
• Can solubilize and deliver lipophilic drugs and nutraceuticals
• Offer improved absorption and bioavailability compared to conventional emulsions
• Examples include self-nanoemulsifying drug delivery systems (SNEDDS) and parenteral nanoemulsions

Lipid-based micelles

• Self-assembled nanostructures formed by amphiphilic lipids in aqueous media
• Consist of a hydrophobic core for drug solubilization and a hydrophilic shell for stability
• Can enhance the solubility and delivery of poorly water-soluble drugs
• Examples include polymeric micelles, phospholipid micelles, and mixed micelles

Composition and structure

• The composition and structure of lipid nanostructures play a crucial role in their properties and performance
• Understanding the components and their organization is essential for designing effective lipid-based nanomedicines

Lipid components

• Various lipids can be used to form nanostructures, including phospholipids, glycolipids, and fatty acids
• The choice of lipid depends on the desired properties, such as phase transition temperature, charge, and compatibility with the encapsulated compound
• Examples of commonly used lipids are phosphatidylcholine (PC), phosphatidylethanolamine (PE), and cholesterol

Surfactants and stabilizers

• Surfactants are added to lipid nanostructures to improve their stability and prevent aggregation
• They can be ionic (anionic or cationic), nonionic, or zwitterionic
• Examples of surfactants include poloxamers, polysorbates, and lecithin
• Stabilizers, such as polyethylene glycol (PEG), can be incorporated to enhance circulation time and reduce immune recognition

Core-shell structure

• Many lipid nanostructures exhibit a core-shell architecture
• The core can be aqueous (liposomes) or lipidic (SLNs, NLCs) and serves as a reservoir for the encapsulated compound
• The shell is composed of lipids and provides a barrier between the core and the external environment
• The core-shell structure influences drug loading, release kinetics, and interactions with biological systems

Lamellar vs non-lamellar phases

• Lipids can self-assemble into different phases depending on their molecular geometry and environmental conditions
• Lamellar phases, such as bilayers in liposomes, are characterized by a parallel arrangement of lipid layers
• Non-lamellar phases, such as hexagonal and cubic phases, exhibit more complex three-dimensional structures
• The phase behavior of lipids affects the stability, drug release, and cellular uptake of nanostructures

Size and shape characteristics

• The size of lipid nanostructures typically ranges from 20 to 1000 nm
• Smaller sizes (<200 nm) are preferred for systemic delivery and tumor targeting due to enhanced permeation and retention (EPR) effect
• The shape of nanostructures can be spherical, ellipsoidal, or irregular, depending on the composition and preparation method
• Size and shape influence the biodistribution, cellular uptake, and drug release profiles of lipid nanostructures

Preparation methods

• Various methods have been developed to prepare lipid nanostructures with desired properties and drug loading
• The choice of method depends on the type of nanostructure, lipid composition, and intended application

Thin-film hydration

• A widely used method for preparing liposomes
• Lipids are dissolved in an organic solvent, which is then evaporated to form a thin lipid film
• The film is hydrated with an aqueous solution, causing the lipids to self-assemble into liposomes
• The resulting liposomes can be further processed by extrusion or sonication to obtain a uniform size distribution

Solvent injection

• A simple and rapid method for preparing lipid nanostructures
• Lipids are dissolved in a water-miscible organic solvent (ethanol or acetone) and rapidly injected into an aqueous phase
• The sudden change in solvent polarity causes the lipids to self-assemble into nanostructures
• Examples include ethanol injection for SLN preparation and microfluidic-based solvent injection for liposomes

High-pressure homogenization

• A scalable method for producing lipid nanostructures with narrow size distribution
• Lipids and the drug are melted and dispersed in an aqueous phase to form a pre-emulsion
• The pre-emulsion is then subjected to high-pressure homogenization, which reduces the particle size and improves uniformity
• Commonly used for the preparation of SLNs and NLCs

Microfluidic techniques

• Microfluidic devices offer precise control over the mixing and self-assembly of lipids
• Lipids and aqueous solutions are introduced into microchannels, where they rapidly mix and form nanostructures
• Advantages include high reproducibility, low sample consumption, and the ability to produce nanostructures with specific sizes and compositions
• Examples include microfluidic hydrodynamic focusing and micromixing for liposome preparation

Supercritical fluid technology

• Supercritical fluids, such as supercritical carbon dioxide (scCO2), can be used as solvents for lipid nanostructure preparation
• Lipids and drugs are dissolved in scCO2, which is then rapidly expanded into an aqueous solution
• The rapid expansion causes the formation of lipid nanoparticles with high encapsulation efficiency
• Advantages include the use of non-toxic solvents and the ability to produce nanostructures with controlled size and morphology

Characterization techniques

• Comprehensive characterization of lipid nanostructures is essential for understanding their properties and performance
• Various techniques are used to analyze the size, morphology, composition, and stability of lipid nanostructures

Dynamic light scattering (DLS)

• A non-invasive technique for measuring the size distribution and polydispersity of lipid nanostructures in suspension
• Measures the fluctuations in scattered light intensity caused by the Brownian motion of particles
• Provides information on the hydrodynamic diameter and size distribution of nanostructures
• Limitations include difficulty in distinguishing between different particle populations and sensitivity to large particles or aggregates

Electron microscopy (TEM/SEM)

• Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) provide high-resolution images of lipid nanostructures
• TEM uses a beam of electrons transmitted through a thin sample to form an image, revealing internal structure and morphology
• SEM scans a focused electron beam over the sample surface, providing information on surface topography and morphology
• Sample preparation involves drying and staining, which may cause artifacts or alter the native structure of nanostructures

Atomic force microscopy (AFM)

• A high-resolution scanning probe microscopy technique that provides three-dimensional topographic images of lipid nanostructures
• A sharp tip attached to a cantilever scans the sample surface, and the deflection of the cantilever is measured to generate an image
• Can be performed in ambient or liquid environments, allowing the visualization of nanostructures in near-native conditions
• Provides information on surface properties, such as roughness, elasticity, and interactions with other molecules

Differential scanning calorimetry (DSC)

• A thermal analysis technique that measures the heat flow associated with phase transitions in lipid nanostructures
• Provides information on the melting temperature, enthalpy, and polymorphic behavior of lipids
• Can be used to study the interactions between lipids and encapsulated drugs, as well as the stability of nanostructures
• Examples include the determination of the gel-to-liquid crystalline phase transition temperature of liposomes and the crystallinity of SLNs

X-ray diffraction (XRD)

• A technique that uses X-rays to probe the crystalline structure and phase behavior of lipid nanostructures
• Provides information on the long-range order, lattice spacing, and polymorphic forms of lipids
• Can be used to study the packing and orientation of lipids in lamellar and non-lamellar phases
• Examples include the characterization of the lamellar spacing in liposomes and the identification of crystalline modifications in SLNs

Zeta potential measurement

• A technique that measures the electrical potential difference between the dispersion medium and the stationary layer of fluid attached to the dispersed lipid nanostructures
• Provides information on the surface charge and stability of nanostructures in suspension
• A high absolute zeta potential (> 30 mV) indicates good colloidal stability due to electrostatic repulsion between particles
• Can be used to study the effect of pH, ionic strength, and adsorbed molecules on the surface properties of lipid nanostructures

Encapsulation and drug loading

• The ability to encapsulate and deliver therapeutic agents is a key feature of lipid nanostructures
• Various strategies are used to incorporate drugs with different solubilities and achieve controlled release

Hydrophobic drug incorporation

• Lipophilic drugs can be directly incorporated into the lipid matrix of nanostructures during preparation
• The drug is dissolved or dispersed in the lipid phase before the formation of nanostructures
• Examples include the incorporation of paclitaxel in SLNs and curcumin in liposomes
• The encapsulation efficiency and loading capacity depend on the drug-lipid interactions and the solubility of the drug in the lipid phase

Hydrophilic drug entrapment

• Water-soluble drugs can be entrapped in the aqueous core of liposomes or in the hydrophilic regions of other nanostructures
• The drug is dissolved in the aqueous phase during the preparation of nanostructures
• Examples include the encapsulation of doxorubicin in liposomes and nucleic acids in lipid nanoparticles
• The encapsulation efficiency depends on the volume of the aqueous phase and the permeability of the lipid membrane

Drug loading capacity and efficiency

• Drug loading capacity refers to the amount of drug that can be incorporated into a given amount of lipid nanostructures
• Encapsulation efficiency is the percentage of the initial drug that is successfully encapsulated in the nanostructures
• High drug loading and encapsulation efficiency are desirable to minimize the amount of carrier material and improve the therapeutic efficacy
• Factors influencing drug loading and efficiency include the drug-lipid ratio, the preparation method, and the physicochemical properties of the drug and lipids

Factors affecting encapsulation

• The encapsulation of drugs in lipid nanostructures is influenced by various factors, such as:
  • Drug-lipid interactions: Hydrophobic, electrostatic, and hydrogen bonding interactions between the drug and lipids
  • Lipid composition: The type and ratio of lipids used, which determine the fluidity and permeability of the nanostructures
  • Preparation method: The specific conditions and parameters used during the preparation process
  • Environmental factors: pH, ionic strength, and temperature, which can affect the stability and integrity of the nanostructures

Stimuli-responsive release mechanisms

• Lipid nanostructures can be designed to release their cargo in response to specific stimuli, enabling controlled and targeted drug delivery
• pH-sensitive nanostructures: Lipids that undergo phase transitions or degradation in acidic environments (e.g., tumors, endosomes) can trigger drug release
• Temperature-sensitive nanostructures: Lipids with a phase transition temperature close to body temperature can release drugs upon local heating (e.g., magnetic hyperthermia)
• Enzyme-responsive nanostructures: Lipids that are substrates for specific enzymes (e.g., phospholipases, matrix metalloproteinases) can be degraded to release drugs at target sites
• Light-responsive nanostructures: Photosensitive lipids or incorporated photosensitizers can induce drug release upon exposure to light of a specific wavelength

Stability and storage

• The stability of lipid nanostructures during storage and in biological environments is crucial for their effective application
• Various strategies are employed to enhance the stability and shelf life of lipid-based nanomedicines

Colloidal stability

• Colloidal stability refers to the ability of lipid nanostructures to remain dispersed in a suspension without aggregation or sedimentation
• Factors affecting colloidal stability include particle size, surface charge, and the presence of stabilizers
• Strategies to improve colloidal stability include the use of charged lipids, steric stabilizers (e.g., PEG), and pH adjustment
• Colloidal stability can be assessed by monitoring changes in particle size, zeta potential, and visual appearance over time

Chemical stability of lipids

• Lipids are susceptible to chemical degradation, such as oxidation and hydrolysis, which can compromise the integrity and performance of nanostructures
• Oxidation of unsaturated lipids can be prevented by the addition of antioxidants (e.g., α-tocopherol, BHT) or by using saturated lipids
• Hydrolysis of ester bonds in phospholipids can be minimized by controlling the pH and ionic strength of the storage medium
• The use of lipids with high purity and proper storage conditions can help maintain the chemical stability of nanostructures

Storage conditions and shelf life

• Proper storage conditions are essential to maintain the stability and efficacy of lipid nanostructures over extended periods
• Factors to consider include temperature, humidity, light exposure, and container material
• Refrigeration (2-8°C) or freezing (-20°C) is often recommended to slow down chemical degradation and microbial growth
• The shelf life of lipid nanostructures depends on their composition, preparation method, and storage conditions
• Accelerated stability studies can be performed to estimate the shelf life under different storage conditions

Lyophilization and reconstitution

• Lyophilization (freeze-drying) is a common method for long-term preservation of lipid nanostructures
• The process involves freezing the nanostructure suspension, followed by sublimation of water under vacuum
• Lyoprotectants, such as sucrose or trehalose, are added to prevent particle aggregation and fusion during the freezing and drying steps
• Lyophilized nanostructures have reduced moisture content and enhanced stability, but require reconstitution before use
• Reconstitution involves the addition of an aqueous medium to the lyophilized powder, which should restore the original size and morphology of the nanostructures

Biomedical applications

• Lipid nanostructures have diverse biomedical applications, leveraging their ability to encapsulate and deliver various therapeutic and diagnostic agents
• The choice of lipid nanostructure and the specific application depend on the properties of the encapsulated compound and the target tissue or disease

Drug delivery systems

• Lipid nanostructures can be used to deliver small molecule drugs, peptides, proteins, and nucleic acids
• They can improve the solubility, stability, and pharmacokinetics of the encapsulated drugs
• Examples include liposomal formulations of anticancer drugs (e.g., Doxil), antifungal agents (e.g., AmBisome), and analgesics (e.g., DepoDur)
• Lipid nanostructures can also be designed for controlled release, such as sustained release or triggered release in response to specific stimuli

Targeted therapy

• Lipid nanostructures can be function